Midgard Science

Labs / CDMO: development & manufacturing

Sarcomatrix

Reno, NV, United States · sarcomatrix.com

GMP

On your own

Free. Their own form.

Contact Sarcomatrix directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Sarcomatrix is a clinical-stage rare disease pharmaceutical company developing therapies for muscle-wasting diseases, including Duchenne muscular dystrophy, sarcopenia, and cachexia. It is based in Reno, Nevada, and works on preclinical and early clinical development of muscle regeneration therapies.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Drug discovery platform for muscle-wasting diseases

    Uses SarcoScreen™ to identify and advance novel therapies for muscle-wasting diseases through functional assays on muscle cells.

  • Functional screening of compounds

    Assesses compounds for effects such as enhanced regeneration, protection from injury, and restored contractile function in muscle cells.

  • Translational research

    Supports movement of programs from research into preclinical and IND-enabling studies.

  • IND-enabling studies

    Conducts studies to prepare programs for Investigational New Drug submission.

  • Clinical trial design and execution

    Brings experience in designing and executing clinical trials for muscle disease programs.

  • CMC support

    Provides chemistry, manufacturing, and controls work for therapeutic development.

  • GMP manufacturing

    States that it is initiating GMP manufacturing of main components.

  • Supply chain management

    Works on supply chain planning and partner selection for commercial-grade production.

  • Regulatory strategy

    Manages regulatory communications and has experience securing orphan drug and rare pediatric disease designations.

  • Market access and commercialization support

    Builds brand recognition and navigates market access pathways for therapies.

What they work on

Modalities
Small molecule
Assays and studies
functional assays
Therapeutic areas
Duchenne muscular dystrophy, muscular dystrophy, sarcopenia, cachexia, LAMA2-RD, muscle-wasting diseases
Minimums and prices
Targeting a $5 million raise · An initial $750,000 sought by third quarter of 2025
Sites
Reno, USA
Quality
GMP (Good Manufacturing Practice) (main components) · Quality by design
Address
450 Sinclair Street, Reno, NV 89501 USA

Similar labs. Antheia, CDI Labs, Nuvisan, Sai Life

Found in a contract services directory. Listing built from sarcomatrix.com. Work here? Claim this listing.

Sarcomatrix · Midgard Science